心力衰竭
射血分数
SIRT3
烟酰胺
舒张期
内科学
内分泌学
氧化应激
药理学
代谢物
化学
基因敲除
射血分数保留的心力衰竭
医学
锡尔图因
NAD+激酶
生物化学
血压
细胞凋亡
酶
作者
Yu-Chen Wang,Yen Chin Koay,Calvin Pan,Zhiqiang Zhou,W.H. Wilson Tang,Jennifer Wilcox,Xinmin S. Li,Alexia Zagouras,Francine Z. Marques,Hooman Allayee,Federico E. Rey,David M. Kaye,John O’Sullivan,Stanley L. Hazen,Yang Cao,Aldons J. Lusis
出处
期刊:Circulation Research
[Ovid Technologies (Wolters Kluwer)]
日期:2024-01-24
卷期号:134 (4): 371-389
被引量:17
标识
DOI:10.1161/circresaha.123.322381
摘要
BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) is a common but poorly understood form of heart failure, characterized by impaired diastolic function. It is highly heterogeneous with multiple comorbidities, including obesity and diabetes, making human studies difficult. METHODS: Metabolomic analyses in a mouse model of HFpEF showed that levels of indole-3-propionic acid (IPA), a metabolite produced by gut bacteria from tryptophan, were reduced in the plasma and heart tissue of HFpEF mice as compared with controls. We then examined the role of IPA in mouse models of HFpEF as well as 2 human HFpEF cohorts. RESULTS: The protective role and therapeutic effects of IPA were confirmed in mouse models of HFpEF using IPA dietary supplementation. IPA attenuated diastolic dysfunction, metabolic remodeling, oxidative stress, inflammation, gut microbiota dysbiosis, and intestinal epithelial barrier damage. In the heart, IPA suppressed the expression of NNMT (nicotinamide N-methyl transferase), restored nicotinamide, NAD + /NADH, and SIRT3 (sirtuin 3) levels. IPA mediates the protective effects on diastolic dysfunction, at least in part, by promoting the expression of SIRT3. SIRT3 regulation was mediated by IPA binding to the aryl hydrocarbon receptor, as Sirt3 knockdown diminished the effects of IPA on diastolic dysfunction in vivo. The role of the nicotinamide adenine dinucleotide circuit in HFpEF was further confirmed by nicotinamide supplementation, Nnmt knockdown, and Nnmt overexpression in vivo. IPA levels were significantly reduced in patients with HFpEF in 2 independent human cohorts, consistent with a protective function in humans, as well as mice. CONCLUSIONS: Our findings reveal that IPA protects against diastolic dysfunction in HFpEF by enhancing the nicotinamide adenine dinucleotide salvage pathway, suggesting the possibility of therapeutic management by either altering the gut microbiome composition or supplementing the diet with IPA.
科研通智能强力驱动
Strongly Powered by AbleSci AI